Hanjin is a Cautionary Tale for Distressed Investors

January/February 2017

Journal of Corporate Renewal

Stay Connected

@SkaddenArps

June 18 Recent Developments in the Enforceability of Make-Whole Premiums in the Second Circuit skadden.com/insights/publi…
June 18 Life Sciences Companies May Face More Scrutiny in Using FDA Documents to Dismiss Securities Cases skadden.com/insights/publi…
June 18 The Impact of SEC Staff Guidance on Shareholder Proposals Leaves a Murky Path Forward skadden.com/insights/publi…